Nathanael Fillmore PhD

Adjunct Instructor, Hematology & Medical Oncology

820 Harrison Ave | (617) 638-7012
Nathanael Fillmore
Sections

Hematology & Medical Oncology

Biography

I lead a group at the VA Boston Healthcare System and Harvard Medical School that uses VA clinical, genomic, and imaging data, together with machine learning and statistical methods, in research to improve patient care. We are also working on software and methodological improvements to support these efforts.

Education

Computer Science, PhD, University of Wisconsin Madison

Computer Science, MS, University of Wisconsin Madison

Philosophy/Classical Studies, BA, Carleton College

Publications

Published on 1/14/2025

Ferri GM, Yildirim C, Do NV, Brophy M, Park JS, Munshi NC, Fillmore NR, Edwards CV. Lymphopenia predicts poor outcomes in newly diagnosed multiple myeloma. Blood Adv. 2025 Jan 14; 9(1):78-88. PMID: 39471425.

Published on 1/1/2025

Williams CT, Yildirim C, Dharne M, Abdallah MM, Driver JA, Munshi NC, Fillmore NR, DuMontier C. Ceiling Effect of International Myeloma Working Group Frailty Score in Real-World Population of Older Adults With Cancer. Hematol Oncol. 2025 Jan; 43(1):e70016. PMID: 39673104.

Published on 12/30/2024

Wu JT, Corrigan J, Su C, Dumontier C, La J, Khan A, Arya S, Harris AHS, Backhus L, Das M, Do NV, Brophy MT, Han SS, Kelley M, Fillmore NR. Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer. Cancer Immunol Immunother. 2024 Dec 30; 74(1):34. PMID: 39739108.

Published on 12/23/2024

Lee MH, La J, Brophy MT, Do NV, Edwards CV, DuMontier C, Hobbs GS, Fillmore NR. Psychiatric and substance use disorders predict poor outcomes in older veterans with acute myeloid leukemia. Blood Adv. 2024 Dec 23. PMID: 39715463.

Published on 12/16/2024

Larsen JR, Zheng C, La J, Wu JT, Kelley M, Gaziano JM, Brophy M, Do NV, Kim DH, Driver JA, Dumontier C, Fillmore NR. Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Advanced Non-Small Cell Lung Cancer. Ann Am Thorac Soc. 2024 Dec 16. PMID: 39680869.

Published on 9/26/2024

Ma S, Jiang JY, Kim RB, Chiang E, Theng Tiong JW, Ryu J, Guffey D, Bandyo R, Dowst H, Swinnerton KN, Fillmore NR, La J, Li A. Circulating tumor DNA predicts venous thromboembolism in patients with cancers. J Thromb Haemost. 2025 Jan; 23(1):139-148. PMID: 39341370.

Published on 8/1/2024

La J, Wang L, Corrigan JK, Lang D, Lee MH, Do NV, Brophy MT, Paller CJ, Fillmore NR. Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer. JAMA Netw Open. 2024 Aug 01; 7(8):e2428444. PMID: 39150709.

Published on 7/2/2024

Kim RB, Zhou E, Swinnerton KN, La J, Ma S, Ranjan M, Do NV, Brophy MT, Fillmore NR, Li A. Racial and Ethnic Disparity for Cancer Mortality in General and Single-Payer Healthcare Systems in the United States. J Racial Ethn Health Disparities. 2024 Jul 02. PMID: 38955957.

Published on 7/2/2024

Wu JT, Corrigan J, Su C, Dumontier C, La J, Khan A, Arya S, Harris AHS, Backhus L, Das M, Do NV, Brophy MT, Han SS, Kelley M, Fillmore NR. The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer. Cancer Immunol Immunother. 2024 Jul 02; 73(9):172. PMID: 38954019.

Published on 7/1/2024

Goryachev SD, Yildirim C, DuMontier C, La J, Dharne M, Gaziano JM, Brophy MT, Munshi NC, Driver JA, Do NV, Fillmore NR. Natural Language Processing Algorithm to Extract Multiple Myeloma Stage From Oncology Notes in the Veterans Affairs Healthcare System. JCO Clin Cancer Inform. 2024 Jul; 8:e2300197. PMID: 39038255.

View full list of 80 publications.